2016
DOI: 10.1001/jama.2016.4882
|View full text |Cite
|
Sign up to set email alerts
|

Lyme Disease Serology

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0
2

Year Published

2017
2017
2023
2023

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(4 citation statements)
references
References 8 publications
0
2
0
2
Order By: Relevance
“…Co-infections may also complicate diagnosis and treatment, particularly when only one agent produces a visible infection. In Lyme disease-endemic areas, the presence of an erythema migrans (EM) lesion may be considered sufficient for clinical diagnosis and treatment with antibiotics ( Lantos et al, 2016 ). Failure to investigate potential co-infections may lead to the underdiagnosis of pathogens such as A. phagocytophilum and B. microti .…”
Section: Discussionmentioning
confidence: 99%
“…Co-infections may also complicate diagnosis and treatment, particularly when only one agent produces a visible infection. In Lyme disease-endemic areas, the presence of an erythema migrans (EM) lesion may be considered sufficient for clinical diagnosis and treatment with antibiotics ( Lantos et al, 2016 ). Failure to investigate potential co-infections may lead to the underdiagnosis of pathogens such as A. phagocytophilum and B. microti .…”
Section: Discussionmentioning
confidence: 99%
“…(6). En este caso, la interpretación de la prueba no se realizó con énfasis en el número de bandas, sino en la positividad de bandas individuales, que carecen de valor diagnóstico por sí solas (7). Por otro lado, Cervantes, en su revisión de literatura sobre la enfermedad de Lyme en el Perú, puntualiza que, en cada caso de diagnóstico de enfermedad de Lyme, debe indicarse el kit de ELISA y Western blot empleados, debido a la alta variedad en la sensibilidad y especificidad entre pruebas comerciales, sin embargo, en este caso se desconoce la prueba empleada por los autores (8).…”
Section: Señor Editorunclassified
“…Ta èiau ME ne bu vi mas ar ne pa ste bë ji mas ne pa nei gia li gos diag no zës. Ðiuo me tu priim ta at lik ti se ro lo gi nius ty ri mus, kai ste bi mi anks ty vos dise mi nuo tos ar vë ly vos di se mi nuo tos li gos po þy miai (menin gi tas, ra di ku lo pa ti ja, mo no neu ri tas, vei di nio ner vo para ly þius, ar tri tas, kar di tas), nes, li gai pro gre sa vus, yra bûdin gi pa di dë jae spe ci fi niø an ti kû nø tit rai [42][43]. Ge riau sia nau do ti jaut rius imu no lo gi nius ty ri mus: ELISA (ga li bû ti pa keis tas imu nof luo res cen ci niu ty ri mu (IFA immunofluorescent as say)) bei Wes t ern blot.…”
Section: Aptarimasunclassified